Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
Jul 02, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-20-000082.pdf 0001708138-20-000082.xls
Jul 02, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-20-000081.pdf 0001708138-20-000081.xls
Jun 30, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-20-000078.pdf 0001708138-20-000078.xls
Jun 29, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-20-000027.pdf 0001237899-20-000027.xls
Jun 24, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-20-000076.pdf 0001708138-20-000076.xls
Jun 22, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-20-000025.pdf 0001237899-20-000025.xls
Jun 17, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-20-000074.pdf 0001708138-20-000074.xls
Jun 17, 2020	SC 13D/A	An amendment to a SC 13D filing	View HTML 0001140361-20-014084.pdf 0001140361-20-014084.xls
Jun 16, 2020	S-8	Securities offered to employees pursuant to employee benefit plans	View HTML 0001104659-20-073764.pdf
Jun 16, 2020	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-20-073794.pdf 0001104659-20-073794.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Data provided by Kaleidoscope.

Investors & Media